Cargando…

Comparison of Oxidative Effects of Two Different Administration Form of Oxybutynin in the Potential Target Tissues

Oxybutynin is an important anticholinergic agent that prevents uncontrolled contractions in the treatment of overactive bladder (OAB). However, drugs containing oxybutynin have significant side effects such as dry eyes, dry mouth, increased heart rate, constipation, blurred vision, and confusion. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaltalioglu, Kaan, Tugcu-Demiroz, Fatmanur, Acarturk, Fusun, Balabanli, Barbaros, Coskun-Cevher, Sule
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323524/ https://www.ncbi.nlm.nih.gov/pubmed/30675153 http://dx.doi.org/10.1155/2018/8124325

Ejemplares similares

Phenolic, Antioxidant, Antimicrobial, and In-vivo Wound Healing Properties of Potentilla erecta L. Root Extract in Diabetic Rats
por: Kaltalioglu, Kaan, et al.
Publicado: (2020)

Oxybutynin: an overview of the available formulations
por: McCrery, Rebecca J, et al.
Publicado: (2006)

Oxybutynin as an alternative treatment for hyperhidrosis
por: Delort, Sergio, et al.
Publicado: (2017)

Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006)

Methadone-Induced Hyperhidrosis Treated With Oxybutynin
por: Hong, Joe, et al.
Publicado: (2017)

Oxybutynin topical gel in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2010)

Atypical aquagenic keratoderma treated with oxybutynin chloride
por: Dixit, Niharika, et al.
Publicado: (2018)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Development of oxybutynin chloride topical gel for overactive bladder
por: Lucente, Vincent R, et al.
Publicado: (2011)

Factorial design-assisted spectroscopic determination of oxybutynin hydrochloride
por: Yosrey, Eman, et al.
Publicado: (2021)

Oxybutynin-Induced Hyperthermia in a Patient With Parkinson’s Disease
por: Ahmad, Saad, et al.
Publicado: (2021)

Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
por: Gamble, Tondalaya, et al.
Publicado: (2008)

A Novel Metered Dose Transdermal Spray Formulation for Oxybutynin
por: Bakshi, A., et al.
Publicado: (2008)

Long-term results of oxybutynin use in treating facial hyperhidrosis
por: Wolosker, Nelson, et al.
Publicado: (2014)

A case of probable oxybutynin-induced increase in liver enzymes
por: Alrawashdeh, Haneen, et al.
Publicado: (2018)

Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens
por: Katsuki, Masahito
Publicado: (2023)

Oxybutynin extended release for the management of overactive bladder: a clinical review
por: Arisco, AM, et al.
Publicado: (2009)

Oxybutynin and Tolterodine in a Trial for Treatment of Overactive Bladder in Iranian Women
por: Aziminekoo, Elham, et al.
Publicado: (2014)

Analysis of oxybutynin treatment for hyperhidrosis in patients aged over 40 years
por: Wolosker, Nelson, et al.
Publicado: (2014)

Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
por: Vozmediano-Chicharro, Raúl, et al.
Publicado: (2020)

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
por: Crespo, Carlos, et al.
Publicado: (2018)

Comparison of combined treatment with desmopressin plus oxybutynin and desmopressin plus tolterodine in treatment of children with primary nocturnal enuresis
por: Azarfar, Anoush, et al.
Publicado: (2015)

Randomized trial - oxybutynin for treatment of persistent plantar hyperhidrosis in women after sympathectomy
por: da Silva Costa, Altair, et al.
Publicado: (2014)

Intravesical Oxybutynin for Urgent Bladder Rescue in a Newborn with Posterior Urethral Valves
por: Molina Caballero, Ada, et al.
Publicado: (2019)

Oxidative stress and cellular immunity in patients with recurrent aphthous ulcers
por: Avci, E., et al.
Publicado: (2014)

Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions
por: Angelico, Patrizia, et al.
Publicado: (2005)

Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gel
por: Sand, Peter K, et al.
Publicado: (2011)

Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin
por: Teivelis, Marcelo Passos, et al.
Publicado: (2014)

Desmopressin, Imipramine, and Oxybutynin in the Treatment of Primary Nocturnal Enuresis: A Randomized Clinical Trial
por: Seyfhashemi, Maryam, et al.
Publicado: (2015)

Comparative response of Desmopressin versus Combination Therapy (Desmopressin + Oxybutynin) in Children with Nocturnal Enuresis
por: Kazi, Asiya, et al.
Publicado: (2020)

Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility
por: Schweitzer, Paula K., et al.
Publicado: (2022)

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation
por: Perger, Elisa, et al.
Publicado: (2023)

Reversible Cerebral Vasoconstriction Syndrome Associated With Oxybutynin Use; a Brief Review of Pathophysiology
por: Khan, Wahab J., et al.
Publicado: (2023)

Desmopressin versus Oxybutynin for Nocturnal Enuresis in Children in Bandar Abbas: A Randomized Clinical Trial
por: Ghasemi, Kambiz, et al.
Publicado: (2016)

Acute angle closure glaucoma after hypospadias surgery: A vision-threatening complication of oxybutynin
por: Jain, Divya, et al.
Publicado: (2015)

The Effectiveness of Intravesical Oxybutynin, Propantheline, and Capsaicin in the Management of Neuropathic Bladder following Spinal Cord Injury
por: George, Jacob, et al.
Publicado: (2007)

Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?
por: Vozmediano-Chicharro, Raúl, et al.
Publicado: (2018)

Long-Term Efficacy, Safety, and Tolerability of Modified Intravesical Oxybutynin Chloride for Neurogenic Bladder in Children
por: Honda, Masashi, et al.
Publicado: (2019)

Cost-Utility Analysis of Oxybutynin vs. OnabotulinumtoxinA (Botox) in the Treatment of Overactive Bladder Syndrome
por: Shabir, Habiba, et al.
Publicado: (2021)

Long-term atomoxetine-oxybutynin combination use may be beneficial for the prevention of obstructive sleep apnea
por: Chen, Tien-Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dfqkshlgnahn42hjv20864h0a7